Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > What is going on ?
View:
Post by Ingiboy on Jan 15, 2024 1:01pm

What is going on ?

As we "impatiently"  wait for some update on where Replicel is going in 2024 we consider some of the possible options:
Sell the company
Sell some of the assets
Take the company Private

With the top ten shareholders owning approx. 63 % of the company I think the next move is to take the company private.  It has numerous advantages the biggest being cost of operation savings. So how does Privatization work ?
 From Macmillan:

"A Canadian incorporated public company may structure a going private transaction a number of ways. In Canada, the three most common ways are a Court approved plan of arrangement, a take-over bid (with a squeeze-out or second step transaction to follow, as necessary) or an amalgamation. The choice of structure is driven by numerous factors including which facilitates the fastest path to closing the deal, financing requirements, required security holder approvals, required third party approvals (such as stock exchange, Competition Act (Canada), Investment Canada Act or industry specific regulatory bodies), how liquid or illiquid the stock of the target is and the risks associated with each of these factors. A holistic assessment of these and other deal specific factors is required to assess the likelihood of a transaction successfully completing."
I rule out a Take-Over Bid and an Amalgamation.  That leaves Court Approved Plan of Arrangement. 
What is that ?
From Macmillan:
"Plan of arrangement. In Canada, most going private transactions are effected pursuant to a plan of arrangement. A plan of arrangement is a Court supervised process effected under the provisions of the target public company’s governing corporate statute. A plan of arrangement is typically negotiated between the prospective purchaser and the target public company’s board of directors or a special committee of the board and is subject to both securityholder and Court approval; the latter requiring the Court’s determination that the terms of the arrangement are “fair and reasonable” to the affected parties.

To effect a going private transaction by way of plan of arrangement, parties enter into an arrangement agreement that establishes the principal terms of the transaction. Following the execution of the arrangement agreement, the parties apply to Court for an “interim order”. The interim order describes the process of calling and giving notice of the meeting of securityholders, the conduct of the meeting, and the level of approval by which securityholders of each class must approve the arrangement (generally 66% to 75%, depending on the province of incorporation of the target company and whether the holders of equity securities or creditors of the target will be statutorily required to vote respecting the plan of arrangement). The Court will almost always grant a right of dissent to each securityholder, providing securityholders entitled to vote at the meeting who oppose the proposed transaction to dissent and receive “fair value” for their voting securities as determined by a Court. Once the target public company obtains the interim order, it is required to prepare and distribute a management information circular to securityholders prior to the meeting. A final order of the Court is obtained following the meeting if the securityholders approve the arrangement. Thereafter, provided other closing conditions are satisfied under the arrangement agreement, the transaction may close."

I hi-lited the approval percentage:  66 2/3 % - 75 %

 

 

 
Comment by Year3000 on Jan 15, 2024 4:33pm
I think you're spot on! I don't think there is any other avenue to go down
Comment by bluemoons20 on Jan 16, 2024 11:20am
another option  is to sell the assets  and  pay a dividend to disperse  the  money.  OR  but unlikely  , sell the assets  and then sell the company as a shell  with the cash  to start some new venture  vended in.   That would  be  nice  but likely with 70 million out  , the new  guys  woyld  do ...more  
Comment by MetzGER on Jan 16, 2024 12:42pm
I talked to them. They will give an extensive Update in the Next couple of weeks. There was something to be clarified with Legal and they had to think about their strategy But they will give us a Timeline for next steps regarding Shiseido and an Update regarding Dermal Injector / (i think CE approval). They still seem to be very confident. I am cautiously Optimistic about share price Jump shortly ...more  
Comment by BellEnd on Jan 16, 2024 1:55pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Jan 16, 2024 5:02pm
Metzter you mention you talked to "them". Who is "them" ?   Was that Andrew or just someone who answered the phone ? I am curious in what context they mentioned Shiseido.  I would take anything regarding the Dermal Injector with a "grain of salt" at this point.  We have heard the words FDA Approval for the past 5 years.
Comment by BellEnd on Jan 16, 2024 11:26pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Jan 18, 2024 1:24pm
Bellend I am always cuatiously optomistic something good will happen to Replicel even with the disappointing Arbitration ruling.  What is annoying me is we are now past 3 months with no update on what direction Replicel will now take.  That in my mind is not acceptable. How long does it take to work out the "legal" aspect of whatever they are working on ? Happy to hear that ...more  
Comment by bluemoons20 on Jan 20, 2024 5:07pm
Even with little to go on  seems like there is some interest  with  there being  almost 100,000  on  the  bid   and  37,000  on the  ask.  Maybe  we can have some  sort of market shaping up.   Though  it would be better  at maybe  10 times  the  prices on the board. GLTA
Comment by Ingiboy on Jan 21, 2024 1:35pm
Yes Bluemoons20 it is encouraging to see some interest in buying Replicel shares even if it is at $.055. I am beginning to think that possibly the Privatization idea is not getting a lot of traction from the bigger shareholders. I am quite surprised that the big pharmaceutical companies are not sniffing around Replicel. With the proper injection of research capital RCH-01 is a viable hair ...more  
Comment by bluemoons20 on Jan 21, 2024 4:38pm
If   the  patents have some value  -  $30 million  is  not a great deal. It was interesting that  during the  call  the  name  Shesheido  came  up  at all  as a possible  involvement  so maybe there are still some  talks. Dpes  raise some questions  though  relative to  RCH-o1.  If ...more  
Comment by Ingiboy on Jan 23, 2024 10:05pm
Well Metzger we have burned off one week of the "next couple of weeks".  I have always loved these nebulous time frames that Buckler used and Andrew has now adopted.   O.K.  let's have it.......where is this company going ?  
Comment by BellEnd on Jan 23, 2024 11:02pm
This post has been removed in accordance with Community Policy
Comment by BellEnd on Jan 28, 2024 2:43pm
This post has been removed in accordance with Community Policy
Comment by toniZ1 on Jan 28, 2024 4:57pm
lol... same procedure as always, how can you expect something different?! the only thing that might get us to a good outcome is a buy-out by shiseido, nothing more on the table.  no progress with yofoto after 6 years, no needle machine, noting on the hand except rch01 and also nearly no money in the bank.  this is the endgame and we will get an update once they were able to sell ...more  
Comment by Ingiboy on Jan 31, 2024 3:39pm
Never quite sure what "the next couple of weeks" really means with Replicel. It has been 16 days since Metzger's phone conversation with Andrew. That is 16 days "to be clarified with legal and they had to think about their strategy".    We are now ready to hear the plan.....  I think the shareholders deserve some information about their investment.  It ...more